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Abstract
Background: The availability and effectiveness of decision aids (DAs) on early abortion 
methods remain unknown, despite their potential for supporting women’s decision 
making.
Objective: To describe the availability, impact and quality of DAs on surgical and medi-
cal early abortion methods for women seeking induced abortion.
Search strategy: For the systematic review, we searched MEDLINE, Cochrane Library, 
CINAHL, EMBASE and PsycINFO. For the environmental scan, we searched Google 
and App Stores and consulted key informants.
Inclusion criteria: For the systematic review, we included studies evaluating an early 
abortion method DA (any format and language) vs a comparison group on women’s 
decision making. DAs must have met the Stacey et al (2014). Cochrane review defini-
tion of DAs. For the environmental scan, we included English DAs developed for the 
US context.
Data extraction and synthesis: We extracted study and DA characteristics, assessed 
study quality using the Effective Practice and Organization of Care risk of bias tool and 
assessed DA quality using International Patient Decision Aid Standards (IPDAS).
Results: The systematic review identified one study, which found that the DA group 
had higher knowledge and felt more informed. The evaluated DA met few IPDAS cri-
teria. In contrast, the environmental scan identified 49 DAs created by non- specialists. 
On average, these met 28% of IPDAS criteria for Content, 22% for Development and 
0% for Effectiveness.
Conclusions: Research evaluating DAs on early abortion methods is lacking, and al-
though many tools are accessible, they demonstrate suboptimal quality. Efforts to re-
vise existing or develop new DAs, support patients to identify high- quality DAs and 
facilitate non- specialist developers’ adoption of best practices for DA development 
are needed.
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1  | INTRODUCTION
As we have described previously,1 women in the United States value re-
ceiving quality information2-4 and support5 when making decisions about 
early abortion.6-9 The two recommended methods, surgical and medical 
abortion, are both highly effective, safe and acceptable, yet differ across 
several aspects (eg duration, bleeding and cramping profile, where the 
abortion takes place, follow- up visit requirements).10 According to a re-
cent national survey of abortion providers,11 both methods are avail-
able in a majority of abortion facilities, and among those facilities that 
offer only the medical option, most are located in areas also served by 
those that offer surgical abortion.11 Recent changes to the US Food and 
Drug Administration regulations for mifepristone- misoprostol medical 
abortion are also anticipated to expand access to women.12 Given the 
potential availability of both methods, and that they are similarly effec-
tive yet encompass very different processes, women’s preferences and 
circumstances are paramount to their method choice.
Decision aids are tools designed to support patients to compare 
medically appropriate options and make informed decisions based on 
their preferences and quality evidence.13 They enable standardized, 
patient- centred and balanced information provision and have been 
shown to improve patients’ knowledge, participation in decision 
making and the alignment between their choices and their values in 
a range of clinical settings.13 Decision aids are particularly relevant 
for the early abortion context given the prevalence of biased infor-
mation about abortion,14 relatively poor knowledge about the safety 
and consequences of abortion among the general public15,16 and the 
diminishing access to qualified abortion providers17 who often serve 
as an important source of trusted information.16 Moreover, because 
primary care providers sometimes have insufficient knowledge18 and 
training19 in early abortion methods, and counselling is not always 
well received from abortion providers,20 integrating a consistent, 
high- quality decision aid may help health professionals across dis-
ciplines to better support women’s decision  making process. Even 
in areas where there may not be ready access to both methods, a 
decision aid may enable women to develop accurate expectations 
about the method that will be used and may also empower women 
as consumer advocates. Despite the potential utility of a decision aid 
on early abortion methods, we lack knowledge on the availability, 
quality and impact of existing decision aids on this topic.
The most recent Cochrane review of decision aids13 and two other 
systematic reviews21,22 identified a single study evaluating an early abor-
tion method decision aid,23 which is no longer available to the public. 
However, none of these reviews assessed the quality of identified deci-
sion aids. Additionally, because these reviews included only randomized 
controlled trials, whether other decision aids have been developed and 
evaluated using non- randomized study designs or developed and eval-
uated but not published in the scientific literature is unknown. What 
also remains unclear is the availability and quality of decision aids that 
have not undergone evaluation, including those developed by entities 
without specialist expertise in decision aid design (eg abortion clinics). 
Such decision aids may be more easily accessed by the general public 
and thus more likely to be the first- line source of information.
The two objectives of this study were (i) to conduct a systematic 
review to identify, appraise and evaluate the impact of early abortion 
method decision aids described in the scientific literature, and (ii) to 
conduct an environmental scan of the grey literature to identify and 
appraise other early abortion method decision aids developed in the 
United States.
2  | METHODS
Study methods are described in detail in a published study protocol1 
and summarized below.
2.1 | Systematic review (Part I)
We registered the systematic review protocol on 12 February 2015 
with the International Prospective Register of Systematic Reviews 
(CRD42015016717), and this reporting adheres to the PRISMA 
methodology.24
2.1.1 | Inclusion and exclusion criteria
We included studies if they were randomized controlled trials or 
non- randomized, cohort, case- control, before- and- after, interrupted 
time series or repeated- measures studies.25 They must have 
included women eligible for and facing a decision between medical 
and surgical abortion (as defined by trialists), and collected patient- 
or observer- reported data on the impact of an early abortion method 
decision aid on women’s decision  making processes or outcomes. 
Our primary outcome was decision quality, defined as the extent 
to which a patient’s decision is informed and based on personal 
values.26-28
The decision aid must have met the definition adopted in the 
Cochrane review of decision aids available at the time the study was 
designed (ie “interventions designed to help people make specific and 
deliberative choices among options (including the status quo), by making 
the decision explicit and by providing (at the minimum) (i) information on 
the options and outcomes relevant to a person’s health status, and (ii) 
implicit methods to clarify values” (Stacey et al, p. 829)), compared 
K E Y W O R D S
abortion, decision aid, environmental scan, informed choice, pregnancy termination, systematic 
review
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medical and surgical early abortion methods,* been publicly available (ie 
free) and been developed after 2000, when medical abortion became 
legal in the United States.30 The decision aid could have been designed 
for use at any time, in any format (eg electronic documents, static web-
sites, interactive websites, videos, DVDs, pamphlets, booklets, smart-
phone mobile applications (“apps”)) and in any language.
After finalization of the study protocol,1 we elected also to ex-
clude studies of women whose gestational age was unclear and stud-
ies evaluating decision coaching not accompanied by a physical tool.31
2.1.2 | Search strategy
We searched MEDLINE/PubMed, The Cochrane Library, CINAHL, 
EMBASE and PsycINFO using, where appropriate, medical subject head-
ing (MeSH) terms: “abortion, induced,” “patient education,” “choice be-
havior,” “decision making” and “decision support techniques” and/or key 
words with Boolean operators. We did not apply any language limits but, 
reflecting decision aid inclusion criteria, we searched only for studies 
published since January 2000, as described above. We also searched the 
trial registry ClinicalTrials.gov, manually searched the reference list of the 
included article (see Results) and considered for inclusion any decision aid 
identified from the environmental scan that had been evaluated and pub-
lished in a peer- reviewed outlet. We also reviewed any articles identified 
in Google Scholar as having cited the included article. All searches were 
conducted in February 2015 (search results included in Appendix S2).
2.1.3 | Screening process
The screening and full review process of Internet pages and apps is 
described in full in the protocol.1 We had planned to screen both titles 
and abstracts of all articles after duplicate entries were removed,32 
but ultimately opted to screen only titles unless further clarification 
from the abstract was needed. This screening approach has been 
shown to be as precise and more efficient than screening both titles 
and abstracts.33 The primary reviewer (KD) classified each article as 
“potentially eligible” or “ineligible” for inclusion and, for articles classi-
fied as “ineligible,” recorded the most salient reason. We had planned 
that the secondary reviewer (RT) would independently screen random 
samples of 10% of the titles and/or abstracts in each classification (ie 
“potentially eligible” and “ineligible”). However, because the primary 
reviewer only identified 12 “potentially eligible” studies (see Results), 
the second reviewer independently screened all of these studies (in 
addition to the 10% of “ineligibles”). The reviewers’ classifications 
matched exactly. The same process was used for full- text review.
2.1.4 | Data extraction
The primary and secondary reviewers used a customized form to inde-
pendently extract data on the study design, participant characteristics, 
decision aid characteristics (eg format, mode of administration) and 
outcomes for the identified study. Abstracted data were compared 
and disagreements resolved by discussion.
2.1.5 | Study and evidence quality appraisal
Both reviewers independently assessed the methodological qual-
ity using the Cochrane Effective Practice and Organization of Care 
Group’s (EPOC) risk of bias criteria.34
2.1.6 | Decision aid quality appraisal
The quality of the decision aid evaluated in the included study was as-
sessed by the primary and secondary reviewers using the 2005 version 
of the International Patient Decision Aid Standards (IPDAS) checklist.35 
This checklist includes items in the Content domain (ie the information, 
probabilities, values clarification and guidance in deliberation specific to 
the health condition), Development domain (ie the design and develop-
ment process) and Effectiveness domain (ie outcomes related to a high- 
quality decision).35 Because the included study did not comprise decision 
aids on a diagnostic test, there were 59 potentially relevant items, includ-
ing supplementary items for Internet- based tools (6 items) and tools that 
included patient stories (3 items). On the quality appraisal form devel-
oped for this study, minor clarifications or examples were added to some 
checklist items to improve clarity and thus consistency in appraisal across 
reviewers (form available in Appendix S1). Items that could not be confi-
dently assessed with the information available were coded as not having 
met the criteria. Items that were not applicable were coded as such.†
We used the Flesch- Kincaid test analytics in Microsoft Word to 
assess the readability and reading ease (scale 0- 100, higher is easier to 
read) of text- based decision aids.36,37 We chose a readability level of 
8th grade or below to indicate limited reading skills IPDAS (Item 42) 
and to correspond with the mean reading level in the US population.38
2.1.7 | Analysis
We had planned to perform a meta- analysis of study results, but only 
one eligible study was identified.
2.2 | Environmental scan (Part II)
2.2.1 | Inclusion and exclusion criteria
For the environmental scan, we adopted all intervention inclusion and 
exclusion criteria used in the systematic review and imposed two fur-
ther criteria, excluding decision aids not written in English and those 
not created by a source in the United States, for women living in the 
United States.
2.2.2 | Search strategy
We conducted four Google searches using the following search 
strings: (i) abortion options, (ii) abortion decision aid, (iii) medical or 
*Decision aids that included other pregnancy options (eg adoption and/or continuing the 
pregnancy) were included so long as they also compared medical and surgical early abortion 
methods.
†There were two exceptions for Internet- based decision aids: those that comprised only one 
tab and did not provide external links were coded as having met Items 44 and 48, 
respectively.
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surgical abortion, and (iv) pregnancy termination options. We searched 
the Apple App Store and Google Play39 using the key word abor-
tion. We also solicited information about decision aids via the 
National Abortion Federation and Abortion Care Network list-
servs and Twitter, emailed key informants who work in abortion 
care and/or research (ie The American Congress of Obstetricians 
and Gynecologists, Planned Parenthood Federation of America, 
Reproductive Health Access Project), and reviewed the Ottawa 
Hospital Research Institute’s Decision Aid Library Inventory.40 
Additionally, the decision aid identified during the systematic review 
was considered for the environmental scan. All searches were con-
ducted in February 2015.
2.2.3 | Screening process
The screening and full review process of Internet pages and apps is 
described in full in the protocol.1 We had planned to classify tools as 
“eligible” or “ineligible” for inclusion, but elected to add “unclear” as a 
third classification due to unforeseen challenges in categorizing some 
of the resultant tools. We contacted two study authors for clarifying 
information about the study population, outcomes and intervention.
The inter- rater reliability of eligible and ineligible classifications be-
tween the primary and secondary was calculated to be κ = 0.74, and 
thus exceeded our minimum requirement (0.7). For those classified 
as “unclear,” the primary and secondary reviewers came to a decision 
about eligibility together.
2.2.4 | Data extraction
The primary reviewer used a customized form to extract data from all 
eligible decision aids (eg format, characteristics and source).
2.2.5 | Decision aid quality appraisal
The primary reviewer appraised the quality of all included decisions 
using the IPDAS checklist and the Flesch- Kincaid tests. The second-
ary and tertiary (GE) reviewers independently appraised the quality 
of random samples of 10% of the eligible decision aids. Inter- rater 
reliability for decision aid quality appraisals was calculated to be 
κ = 0.74 and κ = 0.85, and again exceeded our minimum requirement.
3  | RESULTS
3.1 | Systematic review
Altogether, 2930 unique articles were identified through database 
searches and other search methods. Of those articles classified as 
“potentially eligible” for inclusion, only one described a study that 
met all eligibility criteria (see Figure 1). This study was the randomized 
controlled trial identified in prior systematic reviews.13,21,22 It was 
conducted in 2002 in the United Kingdom and randomized women 
to receive either a three- page paper decision aid about early abortion 
methods (n = 163) or a control leaflet about contraception (n = 165) 
F IGURE  1 Systematic review PRISMA 
flow diagram
Articles identified through database 
searching (n = 3294)
• PubMed – 1904
CINAHL – 292
Cochrane Library – 112
• EMBASE – 574
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• Articles citing included study – 20
Articles after duplicates removed
(n = 2930 )
Articles screened
(n = 2930)
Excluded (n = 2918 )
• Date – 1271
• Design – 1096
• Intervention – 461
• Population – 90
Full-text article assessed 
(n = 12)
Excluded (n = 11)
• Design – 5
• Intervention – 4
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(n = 1)
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in the waiting room before an abortion counselling consultation. We 
contacted the corresponding author to clarify the study outcomes and 
to inquire about related publications (eg study protocols, companion 
studies), none of which were identified.
3.1.1 | Decision aid impact
The included study found that women randomized to receive the de-
cision aid had higher levels of knowledge about both methods, had 
more favourable scores on the Informed subscale of the Decisional 
Conflict Scale and expressed more positive attitudes towards medical 
abortion than women randomized to receive the control leaflet. No 
differences were found between groups in scores on the Uncertain or 
Effectiveness subscales of the Decisional Conflict Scale, level of anxi-
ety, attitudes towards surgical abortion or chosen abortion method. 
Although there were mixed findings about the effect of group on risk 
perception scores about each method, generally, women in the deci-
sion aid group had lower scores. Other study outcomes are described 
in the Cochrane Collaboration review of decision aids13 and the two 
other systematic reviews mentioned previously.21,22
3.1.2 | Decision aid quality appraisal
The decision aid met 5 of 23 IPDAS criteria for the Content domain 
of the IPDAS checklist, 11 of 20 for Development and 1 of 7 for 
Effectiveness. The Flesch- Kincaid readability was calculated to be US 
grade level 6.9 and 62.9 reading ease.
3.1.3 | Study and evidence quality appraisal
Using the EPOC risk of bias criteria, the study was classified as hav-
ing low risk of bias in five of nine domains (see Table 1). The study 
was classified as having high risk of bias in two domains: contamina-
tion  (because randomization was at the patient level) and selective 
outcome reporting (because they used the entire Decisional Conflict 
Scale but only reported select subscales). The risk of bias was unclear 
for similar baseline characteristics (because no baseline outcome 
TABLE  1 Effective Practice and Organization of Care risk of bias 
assessment
Criteria Unclear Low High
Sequence generation ✓
Allocation concealment ✓
Similar baseline outcome 
measurements
✓
Similar baseline characteristics ✓
Blinding ✓
Incomplete outcome data ✓
Contamination ✓
Selective outcome reporting ✓
Other sources of potential bias ✓
F IGURE  2 Environmental scan PRISMA 
flow diagram
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assessed for eligibility
(n = 434)
Tools excluded (n = 385)
• Not a decision aid (n = 341)
• Not about early abortion (n =
29)
• International (n = 5)
• Not English (n = 3)
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• Not working (n = 3)
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IPDAS rating and content 
analysis
(n = 49)
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measurements were obtained) and for blinding (because no primary 
outcome was specified). No other sources of potential bias were 
identified.
Due to the identification of only one study, we were not able to 
use the Grading of Recommendations Assessment, Development 
and Evaluation (GRADE) criteria to rate the quality of evidence as 
planned.41
3.2 | Environmental scan
Altogether, 434 unique tools were identified through Internet and App 
Store searches and other sources. Of these, 49 met eligibility criteria 
(see Figure 2). Three sources referenced a decision aid, but we were un-
able to obtain them despite attempts to contact the authors. The vast 
majority of the excluded tools did not meet the definition of a decision 
aid (ie they failed to make the decision explicit and/or to include implicit 
methods to clarify values (n = 341)).29 The decision aid identified in the 
systematic review did not meet eligibility criteria for the environmental 
scan because it was not created for women in the United States.
3.2.1 | Decision aid characteristics
Most of the included decision aids (n = 42) were non- interactive 
multipage websites that averaged 14.6 pages in length (range 2- 208 
pages). The remaining decision aids comprised 4 Apple Smartphone 
apps, 2 PDFs and 1 video. All decision aids appeared to be cre-
ated by entities without specialist expertise in decision aid devel-
opment, including 32 by abortion services, seven by reproductive 
health- related organizations, four by consumer health information 
organizations, four by pregnancy clinics that do not provide abor-
tion procedures or referral, one by a clinician and one by a patient 
advocate. All decision aids compared at least one method of early 
surgical and medical abortion, with the majority describing some 
type of early surgical abortion to medical abortion with mifepristone 
and misoprostol. Three decision aids also compared manual vacuum 
aspiration to electrical vacuum aspiration. Thirteen decision aids 
also described methotrexate and one, tamoxifen, as alternatives to 
mifepristone.
3.2.2 | Decision aid quality
On average, the decision aids met the criteria for 28% (n = 6) of the 
23 items for Content (range: 3- 12) and 0% (n = 0) of the 7 items for 
Effectiveness domains (see Figure 1). Due to the nature of the included 
decision aids, the number of applicable items in the Development do-
main varied from 18 to 27, with an average of 22% (n = 5) of items met 
(range: 2- 11). Table 2 provides an overview of the average scores (and 
ranges) for different types of decision aids. A table of scores by each 
decision aid is available upon request.
The decision aids met more IPDAS items in the Content and 
Development domains than in the Effectiveness domain, as described 
in Table 3 with clarifying comments.
4  | DISCUSSION
This systematic review and environmental scan found that very lim-
ited research has examined the impact of early abortion method deci-
sion aids, and although many are highly accessible, their quality scores 
are suboptimal. The low scores can be attributed, in part, to many 
decision aids describing method features inconsistently and with un-
equal detail, and presenting information in a disorganized fashion, 
potentially undermining perceptions of balance among users42 and 
impeding values- consistent decision making. This is likely exacerbated 
among women with low literacy given that the majority of decision 
aids did not meet readability standards.38
The poor quality of existing early abortion methods decision aids 
not only represents a lost opportunity for supporting women’s deci-
sion making, but may also affect their care experiences. For exam-
ple, most tools did not describe the emotional and/or social effects 
of one or both methods transparently, so women who are concerned 
with these attributes may develop preferences for a less appropriate 
method. Because some women report choosing their method be-
fore approaching the health system,9 health professionals who offer 
abortion services, counselling and/or referral may need to be pre-
pared to spend more time addressing such misperceptions and offer-
ing evidence- based counselling, particularly among women with low 
Decision aid type Content Development Effectiveness
Website with 
narratives (n = 4)
6.5/23 = 28%  
(range: 6- 9)
6.5/27a = 24%  
(range: 6- 7)
0/7 = 0%
Website without 
narratives (n = 38)
6.6/23 = 29%  
(range: 3- 12)
5.6/24b = 23%  
(range: 2- 11)
0/7 = 0%
PDF (n = 2) 6/23 = 26%  
(range: 6)
4.5/20c = 23%  
(range: 4- 5)
0/7 = 0%
Smartphone app (n = 4) 4/23 = 17%  
(range: 4)
4/23d = 17%  
(range: 4)
0/7 = 0%
Audiovisual (n = 1) 7/23 = 30% 2/18e = 11% 0/7 = 0%
The denominator varied based on the number of applicable IPDAS items. Items that were not applica-
ble are indicated as such: a46, 47; b46, 47, 50, 51, 52; c44, 45, 46, 47, 48, 49, 50, 51, 52; d46, 47, 48, 50, 
51, 52; e41, 42, 44, 45, 46, 47, 48, 49, 50, 51, 52.
TABLE  2 Average International Patient 
Decision Aid Standards scores for different 
types of decision aids
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TABLE  3 Number of decision aids that met each International Patient Decision Aid Standards (IPDAS) criteria
IPDAS criteria n Comments
Content
Describe the health condition 32/49 Sometimes failed to explain that abortion is performed to end a pregnancy.
List the options 49/49
List the option of doing nothing 18/49 Majority did not list the alternative options (ie adoption or continuing the 
pregnancy).
Describe the natural course without options 6/49 Few included information about the process of continuing the pregnancy.
Describe procedures 38/49
Describe positive features 35/49
Describe negative features of options 46/49
Include chances that positive and negative outcomes 
may happen
0/49 Descriptions typically comprised qualitative information (eg “you may 
experience heavy bleeding”) instead of probabilities on the likelihood of 
experiencing certain outcome.
Use event rates specifying the population and time 
period
0/49 Quantitative data were used selectively (eg success or failure rates were 
commonly provided, but not rates for other positive and negative 
outcomes).
Compare outcome probabilities using the same 
denominator, time period, scale
0/49
Describe uncertainty around probabilities 18/49 Descriptions were usually qualitative (eg “you cannot predict what exactly 
will happen to you” or “the [side effect] may happen”).
Use visual diagrams 1/49
Use multiple methods to view probabilities (words, 
numbers, diagrams)
0/49
Allow the patient to select a way of viewing 
probabilities
0/49
Allow the patient to view probabilities based on their 
own situation
0/49
Place probabilities in context of other events 0/49 The risk of having an abortion was often described in relative terms and the 
“risk” was not defined (eg “far less than the risk of carrying a pregnancy and 
giving birth”)
Use both positive and negative frames 0/49 Frequently gave success or failure rates, but rarely provided both.
Describe the procedures and outcomes to help patients 
imagine what it is like to experience their physical, 
emotional and social effects
17/49 All included some description of the methods’ physical effects, but often 
omitted the emotional and/or social effects of one or both methods.
Ask patients to consider what positive and negative 
features matter most
29/49 Majority provided implicit values clarification methods (eg table, list of pros 
and cons, list of reasons why women choose one vs the other) and omitted 
explicit values clarification methods.
Suggest ways for patients to share what matters most 
with others
2/49
Provide steps to make a decision 2/49
Suggest ways to talk about the decision with a health 
professional
3/49
Include tools to discuss options with others 7/49 Infrequently provided question lists, which sometimes had limitations (eg 
only included questions for surgical abortion or listed generic and not 
applicable questions, such as “will this surgery be laparoscopy or open 
surgery?”). Women were rarely encouraged to write down their own 
questions.
Development
Able to compare positive and negative features of 
options
28/49 The type, amount and organization of information given for each method 
was often inconsistent. Information was commonly presented in blocks of 
text under subcategories (eg side- effects) or as answers to frequently asked 
questions, yet the content was often presented in different orders and with 
varying levels of detail. When information was presented in a table (n = 18), 
there was more consistency and equitable detail.
(Continues)
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IPDAS criteria n Comments
Show negative and positive features with equal detail 24/49 The majority described the positive or negative features inconsistently, with 
the negative features emphasized more often.
Include developers’ credentials/qualifications 9/49
Find out what users need to discuss options 0/49
Has peer review by patient/professional experts not 
involved in development and field testing
0/49
Is field tested with users 0/49
The field tests with users show the decision aid is 
acceptable
0/49
The field tests with users show the decision aid is 
balanced for undecided patients
0/49
The field tests with users show the decision aid is 
understood by those with limited reading skills
0/49
Provide reference to evidence used 6/49
Report steps to find, appraise, summarize evidence 0/49
Report date of last update 49/49
Report how often patient decision aid is updated 2/49
Describe the quality of the scientific evidence 0/49
Use evidence from studies of patients similar to those of 
target audience
6/49
Report source of funding to develop and distribute the 
decision aid
0/49
Report where authors or their affiliations stand to gain 
or lose by choices patients make after using the 
decision aid
0/49
Is written at a level that can be understood by the 
majority of patients in the target group.
9/48
Is written at a grade 8 equivalent level or less according 
to readability score
11/48 The average US grade level required to understand the material was 9.6 
(range: 5.1- 12) and the reading ease was 51.3 (range: 31.7- 65.1).
Provide ways to help patients understand information 
other than reading
33/49 The majority indicated that in- person counselling would be available.
Provide a step- by- step way to move through the web 
pages
34/46
Allow patients to search for key words 12/46
Provide feedback on PHI that is entered into the patient 
decision aid
0/0
Provide security for PHI entered into the decision aid 0/0
Make it easy for patients to return to the decision aid 
after linking to other web pages
20/46
Permit printing as a single document 14/46
Use stories that represent a range of positive and 
negative experiences
0/4
Report if there was a financial or other reason why 
patients decide to share their story
0/4
State in an accessible document that the patient gave 
informed consent to use their stories
0/4
Effectiveness
TABLE  3  (Continued)
(Continues)
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literacy. This exchange may be particularly challenging in states that 
mandate the delivery of information during abortion counselling that 
is both inaccurate and not informed by patient preferences,14,43 which 
some providers believe interferes with patient-provider trust and rap-
port.44 This exchange may also lead women to opt for the alternative 
method, potentially inconveniencing both the patient and clinic with 
additional costs and logistical burdens that could have been avoided. 
By partnering with women and health professionals (ie end- users) to 
understand their decision support priorities (eg optimal information 
content, presentation and delivery), there is significant opportunity to 
develop a more quality, relevant and sustainable45-47 early abortion 
method decision aid to promote patient- centred and efficient abortion 
care.48
This study has implications for the current debate on decision aid 
certification.49-51 Our finding that, for this topic, decision aids pro-
duced by entities without specialist expertise in decision aid design 
predominate suggests that a certification approach that encompasses 
only tools produced by specialist developers may miss most of the 
decision aids accessible to patients via the Internet or other chan-
nels. Although reviewing all accessible decision aids for certification 
is clearly unrealistic, we recommend attention be paid to strategies 
for supporting patients to seek and recognize high- quality, certified 
decision aids, and to understand the reasons for their superiority. 
Furthermore, our finding that most of the decision aids met limited 
criteria on the 64- item IPDAS checklist suggests discordance between 
the priorities of subject matter experts and non- specialist developers. 
A certification process that adopts more parsimonious quality criteria, 
such as the IPDAS minimum standards,52 may be the most suitable for 
ensuring decision aids achieve acceptable quality but can still be tai-
lored to reflect real- world needs.53 Simultaneously, efforts to facilitate 
non- specialist developers’ understanding of best practice standards 
for decision development and evaluation, and to encourage submis-
sion of decision aids for review and certification are warranted.
There are four main limitations of this study. First, because our 
focus was on understanding the early abortion method decision aid 
landscape for women in the United States, our systematic review 
excluded studies published before 2000 and thus may have omit-
ted studies conducted earlier in countries with a longer history of 
performing medical abortion. Second, because we elected not to 
contact decision aid developers to solicit further information about 
development and evaluation processes, we may have underestimated 
the quality of some decision aids on these IPDAS domains. Third, be-
cause it was the most comprehensive, we adopted the 64- item IPDAS 
checklist for decision aid appraisal. To our knowledge, this checklist 
has not previously been used to appraise decision aids developed by 
non- specialists and thus may be less well suited to accurately capture 
the strengths and weaknesses of these tools. Lastly, by excluding stud-
ies evaluating decision coaching without an accompanying decision 
aid, we were unable to investigate the impact of different approaches 
to decision support in this context.
These limitations are, however, balanced by several strengths. 
First, we adopted an environmental scan methodology in addition to 
the more traditional systematic review, which proved essential for re-
liably understanding the current decision aid landscape in this area. 
We highly recommend that an environmental scan methodology be 
adopted more widely in attempts to understand the resources or in-
terventions available to patients. Second, unlike a prior study that ad-
opted an environmental scan,54 our methodology purposefully sought 
to identify tools that met the Cochrane definition of a decision aid, 
whether developed by specialists or non- specialists. This prior study 
started with a baseline understanding of a decision aid and included 
only those tools that had a certain focus (ie prenatal testing), which 
likely missed some of the decision aids created by non- specialists. 
Third, we used reliable screening and appraisal tools for the system-
atic review and environmental scan, evidenced by the adequate/high 
agreement between independent reviewers.
5  | CONCLUSIONS
This systematic review and environmental scan demonstrate that 
research examining the impact of decision aids on early abortion 
methods is lacking, despite their potential to address key barriers to 
women’s decision  making process. Although many decision aids on 
this topic have been developed and made accessible in the United 
States, they are mostly poor quality and possibly undermining, 
rather than enhancing, quality decision making by women. Adapting 
an existing decision aid or developing a new decision aid on early 
IPDAS criteria n Comments
Recognize a decision needs to be made 0/49 No evidence of evaluations was found.
Know options and their features 0/49
Understand that values affect decision 0/49
Be clear about option features that matter most 0/49
Discuss values with their practitioner 0/49
Become involved in preferred ways 0/49
Improve the match between the chosen option and 
the features that matter most to the informed 
patient
0/49
TABLE  3  (Continued)
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abortion methods in partnership with end- users and consistent with 
best practice decision aid standards is recommended.
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